Once-daily capsule discloses an individual milligram amount for all seven actives with no proprietary blend, and the company states plainly that each ingredient sits below the doses used in the studies behind them
OGDEN, Utah, Sept. 20, 2026 — MemoHoney today published the complete per-ingredient breakdown of its once-daily cognitive support capsule, along with a side-by-side comparison against the doses used in published research on each ingredient. In every case, the amount in the product is lower than the amount studied, and the company has published those gaps rather than omitting them.
The supplement facts panel declares an individual amount for each of seven actives, with no proprietary blend: niacin at 7.5 mg NE (47% DV), calcium as calcium carbonate at 18 mg (1.5% DV), L-arginine base at 200 mg, L-arginine AKG 2:1 extract at 200 mg, L-citrulline HCl at 100 mg, L-citrulline malate at 100 mg, and beta-alanine at 40 mg. Other ingredients are hypromellose, vegetable stearate and silicon dioxide. Each bottle contains 30 capsules at a labeled serving of one capsule daily.
Why Full Disclosure Is the Announcement
Under 21 CFR 101.36, U.S. supplement manufacturers may group ingredients into a proprietary blend and declare only a combined weight. This is legal and common in the cognitive supplement category, and it makes it impossible for a buyer to compare what they are taking against what has been tested.
MemoHoney does not use that provision. The practical consequence is that the comparison can be made, and the company has made it publicly.
“Anyone can print a study citation on a website, and most brands in this category do,” said Kevin Moore, Product Head at Memo Honey. “What almost nobody prints is the dose the study actually used next to the dose in the bottle. We decided to publish both. Our amounts are below the research doses. A buyer should know that before they order, not find out afterward, and they should weigh it against the price.”
Ingredient Amounts Against Published Research
L-arginine, 400 mg across two forms. L-arginine is the direct substrate that nitric oxide synthase uses to produce nitric oxide. The most relevant cognitive trial is a placebo-controlled study published in Frontiers in Cardiovascular Medicine in 2022 (Mone P, Pansini A, Jankauskas SS, et al., doi:10.3389/fcvm.2022.868521), which randomized 72 frail hypertensive patients over 65 with Montreal Cognitive Assessment scores below 26 to L-arginine or placebo for four weeks at a local health unit in Avellino, Italy, and reported a significant difference in cognitive scores between groups.
Three qualifications apply. The trial used gram-level daily dosing, roughly an order of magnitude above the arginine content of one MemoHoney capsule, and that comparison is before accounting for the salt and conjugate fractions described below. The participants were frail, hypertensive and already cognitively impaired, which is not the general adult population. And the study ran four weeks at a single site.
L-citrulline, 200 mg across two forms. Citrulline is converted to arginine in the kidney and reaches the nitric oxide pathway indirectly. The published trial evidence concerns vascular rather than cognitive endpoints. A systematic review and meta-analysis in Nutrition & Metabolism (Zhu X, et al., 2019, doi:10.1186/s12986-019-0415-y) pooled fourteen trials and reported reductions in brachial systolic and diastolic blood pressure, with the reviewers cautioning that the small number of trials limited the findings. Those trials generally used 3 to 10 g daily. No comparable body of randomized cognitive-endpoint evidence exists for citrulline at any dose.
Learn More about memohoney Ingredients On their official website.
Beta-alanine, 40 mg. Beta-alanine is a carnosine precursor studied mainly in exercise physiology. The direct cognitive evidence is negative. A study in PLOS ONE (Blancquaert L, et al., 2015, doi:10.1371/journal.pone.0123857) gave participants 6.4 g daily for 28 days and found no effect on the brain homocarnosine/carnosine signal and no effect on response times or accuracy across the Stroop test, Sternberg paradigm or Rapid Visual Information Processing task. The International Society of Sports Nutrition position stand identifies 4 to 6 g daily for at least four weeks as the range that meaningfully raises muscle carnosine. The 40 mg here is under 1% of that range, the largest proportional gap in the formula.
Niacin, 7.5 mg NE. Niacin is an essential vitamin and a precursor of NAD and NADP. The recommended dietary allowance is 16 mg NE daily for adult men and 14 mg NE for adult women, per the NIH Office of Dietary Supplements. At 47% of the daily value, the amount here is a partial contribution toward daily requirement rather than a supplemental dose above it. Severe niacin deficiency causes pellagra, which includes cognitive symptoms, but pellagra is rare in industrialized countries and correcting a deficiency is not evidence that intake below the RDA improves memory in adequately nourished adults.
Calcium, 18 mg. At 1.5% of the daily value against an adult requirement of 1,000 to 1,200 mg, this amount is nutritionally negligible. No research is cited for it, because no nutritional effect would be expected at this level.
A Note on How the Amino Acid Weights Should Be Read
Four of the five amino acid entries are salts or conjugates rather than free amino acids, so the declared weights exceed the free amino acid content by an amount the label does not specify. The AKG 2:1 designation indicates two arginine molecules bound to one alpha-ketoglutarate; the HCl and malate forms similarly include a non-amino-acid fraction. Buyers comparing the label to research doses should account for this, which widens rather than narrows every gap described above.
What the Company Is Not Claiming
Memo Honey has not been evaluated in any clinical trial as a finished formula. The research described above concerns individual ingredients under conditions unaffiliated with the company, and it does not establish that the assembled product produces equivalent outcomes.
Most of the research behind arginine and citrulline measured vascular endpoints such as blood pressure and endothelial function, not memory. The proposition that improving cerebral blood flow improves memory in healthy adults is a plausible mechanism, not an established outcome.
“We are not going to claim this product treats anything, because it doesn’t,” Moore said. “If someone is forgetting names and it frightens them, the right response is a physician, not a capsule. Several causes of memory change are treatable once identified, and a supplement delays that conversation.”
Memory Change Is a Clinical Matter
New or worsening memory difficulty, confusion, disorientation, trouble with familiar tasks, or changes in language or personality warrant evaluation by a physician. Several causes of cognitive symptoms, including thyroid dysfunction, vitamin B12 deficiency, medication effects, depression and sleep disorders, are identifiable and treatable, and identifying them requires clinical assessment.
The factors with the strongest evidence base in cognitive aging are sleep, physical activity, cardiovascular health, hearing, social engagement, education, and management of conditions such as hypertension and diabetes. MemoHoney is positioned as an addition to an established routine, not a replacement for any part of one.
Safety Information
Arginine and citrulline act on the nitric oxide pathway, which is also targeted by several medication classes. Anyone taking blood pressure medication, nitrates, or PDE5 inhibitors should consult a prescriber before use because of possible additive blood-pressure lowering. The same applies to anyone on anticoagulant or antiplatelet medication.
People with established cardiovascular disease or a history of heart attack should consult a physician before using any arginine-containing product. A randomized trial of L-arginine at 9 g daily following a first myocardial infarction (Schulman SP, et al., JAMA, 2006;295(1):58–64) was stopped early after higher mortality in the L-arginine group, concentrated among patients 60 and older. That dose is many times the amount here and the population was post-infarction patients, but the finding is relevant to anyone in that group.
The label directs users to take one capsule daily with 8 oz. of water, not to exceed the recommended dose, and states the product is not for anyone under 18. Pregnant or nursing women and anyone with a known medical condition should consult a physician before use.
Pricing and Availability
MemoHoney is sold through the manufacturer’s authorized portal at mymemohoney.com. Three configurations are offered: two bottles at $79 each ($158 plus shipping), three bottles at $69 each ($207, free U.S. shipping), and six bottles at $49 each ($294, free U.S. shipping). No single-bottle option is offered. All purchases are a one-time charge with no auto-ship enrollment. Orders carry a 60-day money-back guarantee; buyers should confirm the exact refund conditions in writing before ordering.
Manufacturing
The label states the product is manufactured in the USA with globally sourced ingredients. It does not name a facility and does not carry an FDA-registration or GMP-certification statement, and no certificate of analysis was published on the pages reviewed. Buyers wanting that documentation should request it from the distributor. Under 21 CFR Part 111, manufacturers must comply with current Good Manufacturing Practice regardless of whether a label says so. No dietary supplement is FDA-approved before marketing.
About Memo Honey
Memo Honey is a dietary supplement brand distributing a once-daily capsule containing niacin, calcium, L-arginine base, L-arginine AKG 2:1 extract, L-citrulline HCl, L-citrulline malate and beta-alanine in 30-capsule bottles. Every active is disclosed with an individual amount and the formula contains no proprietary blend. The product is distributed by Instituto Experience of Ogden, Utah.
Media Contact
Kevin Moore, Product Head
MemoHoney / Instituto Experience
Email: support@mymemohoney.com
Phone: +1 (507) 448-8190
Website: mymemohoney.com
Address: Instituto Experience, PO Box 12730, Ogden, UT 84404, USA
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. Research referenced concerns individual ingredients and does not constitute clinical evaluation of the finished product.
